Theragen Etex Co Ltd

066700

Company Profile

  • Business description

    Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

  • Contact

    58, Sandan-ro 68-gil
    Danwon-gu, Gyeonggi-do
    Ansan-si
    KOR

    T: +82 234637111

    http://www.theragenetex.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    218

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,211.0048.20-0.52%
CAC 408,071.364.680.06%
DAX 4024,309.46513.33-2.07%
Dow JONES (US)49,071.5655.960.11%
FTSE 10010,171.7617.330.17%
HKSE27,613.19354.90-1.27%
NASDAQ23,685.12172.33-0.72%
Nikkei 22553,153.70221.90-0.42%
NZX 50 Index13,389.9041.290.31%
S&P 5006,969.019.02-0.13%
S&P/ASX 2008,912.6042.50-0.47%
SSE Composite Index4,113.9544.04-1.06%

Market Movers